Accueil › Annuaire des chercheurs › Dario Trapani

Dario Trapani

Affiliation : University of Milan · European Institute of Oncology

• 23Publications (affiliation italienne)
• 405Publications au total
• 10583Citations
• 49Indice h

ORCIDOpenAlex

Profil de recherche

Dario Trapani compte 23 publications référencées (2019–2026). Ses travaux paraissent principalement dans « JCO Global Oncology », « European Journal of Cancer » et « Annals of Oncology ». Son article le plus cité, « Repurposing anticancer drugs for the management of COVID-19 » (2020), a été cité 80 fois. 13 de ces publications datent des trois dernières années d’activité. Ses travaux sont cosignés avec au moins 12 chercheurs, notamment dans des établissements de États-Unis, Australie, Suisse.

C’est vous ? Faites connaître vos travaux

Créez gratuitement votre profil DzCademia et ajoutez vos articles : ils apparaîtront plus facilement sur Google et dans les assistants d’IA comme ChatGPT. Plus de personnes pourront vous lire et vous citer.

Créer mon profil gratuit Ajouter mes publications

Domaines de recherche

• Breast Cancer Treatment Studies
• Cancer Immunotherapy and Biomarkers
• Advanced Breast Cancer Therapies
• HER2/EGFR in Cancer Research
• BRCA gene mutations in cancer

Publications (23)

• 17P International survey of TIL assessment in breast cancer: Current use, clinical integration, and implementation barriers
  2026 · ESMO Open
• Acute Oncology Services in Low- and Middle-Income Countries: Current Evidence, Challenges, and Strategic Priorities
  2026 · JCO Global Oncology
• Expanding access to cancer immunotherapy: A systematic review of low-dose PD-(L)1 inhibitor strategies
  2025 · European Journal of Cancer · cité 14 fois
• Low-dose anti-PD-(L)1 inhibitor strategies: A systematic review.
  2025 · Journal of Clinical Oncology
• 2306P Low-dose Anti-PD-(L)1s agents in immune-oncology: Are we prepared?
  2025 · Annals of Oncology
• WHO model list of essential in vitro diagnostics: strengthening diagnostics capacity to transform health care for all
  2024 · The Lancet Global Health · cité 6 fois
• An international survey on the knowledge, attitudes and clinical patterns of use of medical cannabis for cancer care: The TASMAN study
  2024 · European Journal of Cancer · cité 4 fois
• Global Landscape of the Attack of Predatory Journals in Oncology
  2024 · JCO Global Oncology · cité 4 fois
• Integrity matters in oncology: AORTIC takes a stand against research misconduct
  2024 · BJC Reports · cité 2 fois
• Conflict of Interest Disclosure in Oncology: Preliminary Insights From the Global ONCOTRUST-1 Cross-Sectional Study
  2024 · JCO Global Oncology · cité 1 fois
• Depicting oncologists' perceptions and knowledge of global disparities in conflicts of interest reporting: The ONCOTRUST-1 study.
  2024 · Journal of Clinical Oncology
• Considerations for the CHH–Lancet Commission on Health, Conflict, and Forced Displacement
  2024 · The Lancet
• Diversity and Inclusivity Considerations Are Key When Choosing a Global Oncology Conference Location
  2024 · JCO Global Oncology
• New horizons for platinum-resistant ovarian cancer: insights from the 2023 American Society of Clinical Oncology (ASCO) and European Society for Medical Oncology (ESMO) Annual Meetings
  2023 · International Journal of Gynecological Cancer · cité 5 fois
• Exploring the prognostic impact of tumor sidedness in ovarian cancer: A population-based survival analysis of over 10,000 patients
  2022 · Cancer Treatment and Research Communications · cité 2 fois
• The Advent of Circulating Tumor DNA in the Management of Ovarian Cancer
  2021 · Springer eBooks
• Repurposing anticancer drugs for the management of COVID-19
  2020 · European Journal of Cancer · cité 80 fois
• Frequency and types of EGFR mutations in Moroccan patients with non–small cell lung cancer
  2020 · Tumori Journal · cité 16 fois
• Can the microbiota predict response to systemic cancer therapy, surgical outcomes, and survival? The answer is in the gut
  2020 · Expert Review of Clinical Pharmacology · cité 11 fois
• Overview of Cost-Effectiveness and Limitations of Next-Generation Sequencing in Colorectal Cancer
  2020 · Springer eBooks · cité 1 fois
• The Revolution of Liquid Biopsy and Single-Cell Sequencing in the Management of Colorectal Cancer
  2020 · Springer eBooks · cité 1 fois
• Painting the global picture of HER2-testing for breast cancer. The ONCOLLEGE-001 survey study
  2019 · Annals of Oncology · cité 1 fois
• Accessibility and affordability to trastuzumab for breast cancer patients: Voices of the global oncology community from ONCOLLEGE 001 survey, part 2
  2019 · Annals of Oncology

Revues de publication

• JCO Global Oncology × 4
• European Journal of Cancer × 3
• Annals of Oncology × 3
• Springer eBooks × 3
• Journal of Clinical Oncology × 2
• ESMO Open × 1

Publications par année

• 20262
• 20253
• 20248
• 20231
• 20221
• 20211
• 20205
• 20192

Collaborations

Établissements partenaires : Universidad Peruana Cayetano Heredia · University of Michigan · World Health Organization · Regione Campania · University of Campania "Luigi Vanvitelli"

Pays des co-auteurs : États-Unis · Australie · Suisse

Co-auteurs

• Angelica Petrillo
• Giuseppe Curigliano
• Rashad Abdul-Ghani
• Lyu Yunfeng
• Paulinus Nnamdi Offutalu
• Amina Hansali
• Ana Aceves Capri
• Maria Vittoria Dieci
• Gennaro Daniele
• Patricia Jannet Garcia
• Bruno Daniele
• William A. Sewell

Données bibliographiques issues d’OpenAlex (base ouverte).